Furthermore, clinical studies have determined that ER/PR levels in DCIS significantly correlate with tumor grade (i.e. high ER+/PR+ is associated with a lower grade and vice-versa) [61]. The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.